Inhibitory activity of limonene against Leishmania parasites in vitro and in vivo

Biomedicine and Pharmacotherapy

Volumn 63, Issue 9, 2009, Pages 643-649

  Arruda, Denise C ^a   Miguel, Danilo C ^a   Yokoyama Yasunaka, Jenicer K U ^a   Katzin, Alejandro M ^a   Uliana, Silvia R B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemotherapy; Leishmaniasis; Terpene

Indexed keywords

LIMONENE;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA BRAZILIENSIS; LEISHMANIA CHAGASI; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS;

ANIMALS; ANTIPROTOZOAL AGENTS; CYCLOHEXENES; FEMALE; LEISHMANIA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE; PARASITIC SENSITIVITY TESTS; TERPENES;

EID: 72649105116     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.02.004     Document Type: Article

References (31)

1. Desjeux P. Leishmaniasis. Nat Rev Microbiol 2 (2004) 692
2. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health 6 (2001) 849-854
3. Croft S.L., and Engel J. Miltefosine - discovery of the antileishmanial activity of phospholipid derivatives. Trans R Soc Trop Med Hyg 100 (2006) 4-8
4. El-On J., Bazarsky E., and Sneir R. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod. Exp Parasitol 116 (2007) 156-162
5. do Socorro S.M., Rosa R.R., Mendonça-Filho H.R., Bizzo I., de Almeida Rodrigues R.M., Soares T., et al. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob Agents Chemother 47 (2003) 1895-1901
6. Germonprez N., Maes L., Van Puyvelde L., Van Tri M., Tuan D.A., and De Kimpe N. In vitro and in vivo anti-leishmanial activity of triterpenoid saponins isolated from Maesa balansae and some chemical derivatives. J Med Chem 48 (2005) 32-37
7. Torres-Santos E.C., Lopes D., Oliveira R.R., Carauta J.P., Falcao C.A., Kaplan M.A., et al. Antileishmanial activity of isolated triterpenoids from Pourouma guianensis. Phytomedicine 11 (2004) 114-120
8. Tiuman T.S., Ueda-Nakamura T., Garcia Cortez D.A., Dias Filho B.P., Morgado-Diaz J.A., de Souza W., et al. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob Agents Chemother 49 (2005) 176-182
9. Arruda D.C., D'Alexandri F.L., Katzin A.M., and Uliana S.R.B. Antileishmanial activity of the terpene nerolidol. Antimicrob Agents Chemother 49 (2005) 1679-1687
10. El-Kattan A.F., Asbill C.S., Kim N., and Michniak B.B. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm 215 (2001) 229-240
11. Krishnaiah Y.S., and Al-Saidan S.M. Limonene enhances the in vitro and in vivo permeation of trimetazidine across a membrane-controlled transdermal therapeutic system. Curr Drug Deliv 5 (2008) 70-76
12. Raphael T.J., and Kuttan G. Effect of naturally occurring monoterpenes carvone, limonene and perillic acid in the inhibition of experimental lung metastasis induced by B16F-10 melanoma cells. J Exp Clin Cancer Res 22 (2003) 419-424
13. Lu X.G., Zhan L.B., Feng B.A., Qu M.Y., Yu L.H., and Xie J.H. Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene. World J Gastroenterol 10 (2004) 2140-2144
14. Chen J., Lu M., Jing Y., and Dong J. The synthesis of l-carvone and limonene derivatives with increased antiproliferative effect and activation of ERK pathway in prostate cancer cells. Bioorg Med Chem 14 (2006) 6539-6547
15. Vigushin D.M., Poon G.K., Boddy A., English J., Halbert G.W., Pagonis C., et al. Phase I and pharmacokinetic study of d-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother Pharmacol 42 (1998) 111-117
16. National Toxicology Program. NTP toxicology and carcinogenesis studies of d-limonene (CAS No. 5989-27-5) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep 347 (1990) 1-165. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr347.pdf Available at: [accessed 10.03.09]
17. Rodrigues Goulart H., Kimura E.A., Peres V.J., Couto A.S., Aquino Duarte F.A., and Katzin A.M. Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum. Antimicrob Agents Chemother 48 (2004) 2502-2509
18. Kapler G.M., Coburn C.M., and Beverley S.M. Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol Cell Biol 10 (1990) 1084-1094
19. Uliana S.R.B., Goyal N., Freymüller E., and Smith D.F. Leishmania: overexpression and comparative structural analysis of the stage-regulated meta 1 gene. Exp Parasitol 92 (1999) 183-191
20. Titus R.G., Marchand M., Boon T., and Louis J.A. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7 (1985) 545-555
21. Tanaka A.K., Valero V.B., Takahashi H.K., and Straus A.H. Inhibition of Leishmania (Leishmania) amazonensis growth and infectivity by aureobasidin A. J Antimicrob Chemother 59 (2007) 487-492
22. Crowell P.L. Prevention and therapy of cancer by dietary monoterpenes. J Nutr 129 (1999) 775-778
23. Mo H., and Elson C.E. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med 229 (2004) 567-585
24. Sun J. d-limonene: safety and clinical applications. Altern Med Rev 12 (2007) 259-264
25. Robledo S., Osorio E., Muñoz D., Jaramillo L.M., Restrepo A., Arango G., et al. In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives. Antimicrob Agents Chemother 49 (2005) 1652-1655
26. Watkins-Chow D.E., and Pavan W.J. Genomic copy number and expression variation within the C57BL/6J inbred mouse strain. Genome Res 18 (2008) 60-66
27. Miyazawa M., Shindo M., and Shimada T. Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos 30 (2002) 602-607
28. Crowell P.L., Chang R.R., Ren Z.B., Elson C.E., and Gould M.N. Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites. J Biol Chem 266 (1991) 17679-17685
29. Hohl R.J., and Lewis K. Differential effects of monoterpenes and lovastatin on RAS processing. J Biol Chem 270 (1995) 17508-17512
30. Del Toro-Arreola S., Flores-Torales E., Torres-Lozano C., Del Toro-Arreola A., Tostado-Pelayo K., Guadalupe Ramirez-Duenas M., et al. Effect of d-limonene on immune response in BALB/c mice with lymphoma. Int Immunopharmacol 5 (2005) 829-838
31. Raphael T.J., and Kuttan G. Immunomodulatory activity of naturally occurring monoterpenes carvone, limonene, and perillic acid. Immunopharmacol Immunotoxicol 25 (2003) 285-294